» Articles » PMID: 32442347

The Role of ECMO in COVID-19: Can It Provide Rescue Therapy in Those Who Are Critically Ill?

Overview
Journal J Card Surg
Date 2020 May 23
PMID 32442347
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Arising from the city of Wuhan, Hubei province in China, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 has been rapidly spreading since its first presentation in late 2019. The World Health Organization declared a pandemic on the 11th March 2020, and as of 29th of April 2020 more than 3 million cases have been reported worldwide with over 225 000 confirmed deaths. Where mechanical ventilation may not be enough, extracorporeal membrane oxygenation (ECMO) could play a role as a form of rescue therapy and may provide beneficial results in the hands of skilled clinicians in centers with experience of using ECMO appropriately in selected patients. Our understanding of COVID-19 is ever-changing and the need for intensive care beds is rising, which means that ECMO will surely play a key role in the near future.

Citing Articles

Multi-modal prediction of extracorporeal support-a resource intensive therapy, utilizing a large national database.

Zhu D, Xue B, Shah N, Payne P, Lu C, Said A JAMIA Open. 2025; 8(1):ooae158.

PMID: 39764170 PMC: 11702361. DOI: 10.1093/jamiaopen/ooae158.


Factors Associated with Outcomes of Patients with Veno-Venous Extracorporeal Membrane Oxygenation for COVID-19.

Lee S, Kang G, Song S, Lee K, Yoo W, Jang H J Clin Med. 2024; 13(19).

PMID: 39407982 PMC: 11478145. DOI: 10.3390/jcm13195922.


Venovenous extracorporeal membrane oxygenation in COVID-19-related acute respiratory distress syndrome : What's the catch?.

El Gharib K, Narasimhan M Clin Med (Lond). 2023; 23(4):427-428.

PMID: 37399283 PMC: 10541032. DOI: 10.7861/clinmed.2023-0149.


COVID-19 and Multiorgan Response: The Long-Term Impact.

Harky A, AlaAldeen A, Butt S, Duric B, Roy S, Zeinah M Curr Probl Cardiol. 2023; 48(9):101756.

PMID: 37088175 PMC: 10122551. DOI: 10.1016/j.cpcardiol.2023.101756.


Health benefit and economic impact of utilising ECMO in COVID-19 patients: patient or cost first.

Butt S, Shankar M, Amien B, Fedevici O, Harky A Ann Transl Med. 2023; 11(2):33.

PMID: 36819563 PMC: 9929785. DOI: 10.21037/atm-22-6391.


References
1.
Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N . Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009; 302(17):1888-95. DOI: 10.1001/jama.2009.1535. View

2.
Giwa A, Desai A, Duca A . Novel 2019 coronavirus SARS-CoV-2 (COVID-19): An updated overview for emergency clinicians. Emerg Med Pract. 2020; 22(5):1-28. View

3.
Savarimuthu S, BinSaeid J, Harky A . The role of ECMO in COVID-19: Can it provide rescue therapy in those who are critically ill?. J Card Surg. 2020; 35(6):1298-1301. PMC: 7280692. DOI: 10.1111/jocs.14635. View

4.
Zeng Y, Cai Z, Xianyu Y, Yang B, Song T, Yan Q . Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. Crit Care. 2020; 24(1):148. PMC: 7156900. DOI: 10.1186/s13054-020-2840-8. View

5.
Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C . Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018; 378(21):1965-1975. DOI: 10.1056/NEJMoa1800385. View